Alkem Laboratories Limited IPO Message Board (Page 27)

ahmedabad city premium and kostak

Which city premium

1700-1800 interest

ANY UPDATE ON THIS NEWS EVERYONE. IF THIS HOLD TRUE AND COMPANY PENALISED. THERE WOULD BE NEGATIVE IMPACT AS BOTH FDI and CCISuppose to be penalising.

dont forget ths news is just recent. please dont ignore this.

http://www.business-standard.com/article/pti-stories/cci-imposes-rs-74-cr-fine-on-alkem-labs-115120401025_1.html

same article says this been mentioned in draft RHP. so I guess impact shall be minimum. Also 74 cr should not be an issue for Alkem. lets hope for better

APPLY FOR LISTING GAINS ONLY

ALL PHARMA COMPANIES ARE ON HIT LIST OF USA FDA
SUN PHARMA , DR REDDYS RANBAXY ETC ARE ALL DOWN

How will be the allotment done ? If a person applies for 100 shares how many shares he will get approx ?

I will give 5/5 and 4.5/5 rating to Septa and pinkyjain. these people r the rockstars of market. i have been in this group since 5 months. septa is 100 percent correct all the time.

In shk septa was wrong

PinkyJain & Septa
Balle! Balle!!

240-250 bayar

ANY UPDATE ON THIS NEWS. THIS IS RECENT NEWS AND COULD CAGREAT IMPACT

http://www.business-standard.com/article/pti-stories/cci-imposes-rs-74-cr-fine-on-alkem-labs-115120401025_1.html

Looking at the retail response at various brokers offices both these IPO will be subscribed by minimum 3 to 4 times in retail category.after steller listing of indigo no one wants to miss the bus and grey market is also supporting them so need not to worry about subscription figures

Premium 207-211
Apply

Company are having lot of cash reserves. Now they are utilising & playing with public money.

BSE BID DETAILS
ALKEM LABORATORIES LIMITED      
Last updated on 08/12/2015 05:00 PM
Sr.No.      Category      No.of shares offered/reserved      No. of shares bid for      No. of times of total meant for the category
1      Qualified Institutional Buyers (QIBs)      2510906      1018556      0.4100
1(a)      Foreign Institutional Investors(FIIs)            0      
1(b)      Domestic Financial Institutions(Banks/ Financial Institutions(FIs)/ Insurance Companies)            762165      
1(c)      Mutual funds            0      
1(d)      Others            457290      
2      Non Institutional Investors      1883179      176372      0.0900
2(a)      Corporates            0      
2(b)      Individuals(Other than RIIs)            164925      
2(c)      others            0      
3      Retail Individual Investors(RIIs)      4394086      1931454      0.4400
3(a)      Cut Off            1749825      
3(b)      Price bids            253800      
4      Employees      298913      42490      0.1400
3(a)      Cut Off            36315      
3(b)      Price bids            180      
Total      9087084      3168872      0.35


NOW NSE BID DETAILS

Bid Details for ALKEM as on 08-Dec-2015 17:01:29 IST
Sr. No      Category      No of Shares
offered/Reserved      No of shares bid for      No of times of total meant for the category
1      Qualified Institutional Buyers(QIBs)      25,10,906      9,09,356      0.36
1(a)      Foreign Institutional Investors(FIIs)            1,77,828      
1(b)      Domestic Financial Institutions(Banks/ Financial Institutions(FIs)/ Insurance Companies)            6,36,328      
1(c)      Mutual funds            95,200      
1(d)      Others            0      
2      Non Institutional Investors      18,83,179      81,676      0.04
2(a)      Corporates            3,332      
2(b)      Individuals(Other than RIIs)            78,344      
2(c)      others            0      
3      Retail Individual Investors(RIIs)      43,94,086      7,77,210      0.18
3(a)      Cut Off            6,63,474      
3(b)      Price bids            1,13,736      
4      Employees      2,98,913      32,004      0.11
4(a)      Cut Off            31038      
4(b)      Price Bids            966      
Total      90,87,084      18,00,246      0.20



TOTAL .35 +.20 =.55 %

Alkem is most respectable pharma company like indigo is most respectable airlines both are in domestic business so no worry about what happen @out side of country... I wan''t do such a stupid mistake again that i did for INDIGO by reading non experience people''s review from board..

Anchor allocation report looks attractive. 25+ fund houses & banks invested in this IPO. I will wait for last minute subscription details than I will apply for this IPO.

Will avoid both pharma ipo

MR 118 >>>> 119/120 COMENT PADOOOOOOOOOOOO

BEWARE ALKEM FACE VALUE 2 AND PERMIUN CHARGED 1048 WE CAN GO FOR LISTED PHARMA STOCK LIKE WOCKHARDT FACE VALUE 5 MKT PRICE 1637 , IPCA LAB FV 2 MKT PRICE 750,
GLAXOSMITHKLINE PHARMACEUTICALS LTD FV 10 MKP 3265 AND MANY MORE PLS DONT FALL PRAY TO GREEDY PROMOTERS

Wockhard 2plant sealed by usfda and doing loss, ipca lab net profit 1st half 2016 stand @30cr, glax..pharma 1st half 2016 @180cr

Alkem 1st half net profit 400+ cr now compare

LUPIN AND AJANTA PHARMA IS FACE VALU RS 2 ONLY

LUPOINHIGTH RATE 2100 AND AJANTA 1700 NO ANE COMPER

Alkem at 5.00 p.m. = 0.35. Dr. Lal at 5.00 p.m. = 0.65 times

As per latest NSE bid details for

Retail Investors(Retail Individual Investors(RIIs))
Alkem Lab : 0.18(18% of alloted shares)
Dr. LalPathLabs: 0.20(20% of alloted shares)

This IPO wll be heavily oversubscrbed

Alkem GMP 222-225 (Only Seller)